Approaches toward peptide-based immunotherapy of autoimmune diseases (Q35646284)

9 August 2017

1 reference

title

Approaches toward peptide-based immunotherapy of autoimmune diseases (English)

1 reference

9 August 2017

1 reference

L Adorini

1

1 reference

9 August 2017

J C Guéry

series ordinal

2

1 reference

9 August 2017

S Trembleau

series ordinal

3

1 reference

9 August 2017

publication date

1 January 1992

1 reference

Seminars in Immunopathology

9 August 2017

published in

1 reference

9 August 2017

volume

14

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

187-199

1 reference

9 August 2017

1 reference

12 December 2020

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

1 reference

12 December 2020

T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis

1 reference

12 December 2020

The cell biology of antigen processing and presentation

1 reference

12 December 2020

Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.

1 reference

12 December 2020

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

1 reference

12 December 2020

Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.

1 reference

12 December 2020

Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation

1 reference

12 December 2020

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis

1 reference

12 December 2020

Peptide competition for antigen presentation

1 reference

12 December 2020

New perspectives on immunointervention in autoimmune diseases

1 reference

12 December 2020

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments

1 reference

12 December 2020

Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein

1 reference

12 December 2020

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

12 December 2020

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

1 reference

12 December 2020

Delivery of recombinant peptide and protein drugs

1 reference

12 December 2020

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

1 reference

12 December 2020

The distinctive specificity of antigen-specific suppressor T cells

1 reference

12 December 2020

A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules

1 reference

12 December 2020

T cell recognition as the target for immune intervention in autoimmune disease

1 reference

12 December 2020

T cell receptors in murine autoimmune diseases

1 reference

12 December 2020

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

1 reference

12 December 2020

Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules

1 reference

12 December 2020

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

1 reference

12 December 2020

Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1)

1 reference

12 December 2020

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

1 reference

12 December 2020

Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins

1 reference

12 December 2020

Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease

1 reference

12 December 2020

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

1 reference

12 December 2020

Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes

1 reference

12 December 2020

Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals

1 reference

12 December 2020

Immunotherapy by peptides?

1 reference

12 December 2020

Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen

1 reference

12 December 2020

Mechanisms influencing the immunodominance of T cell determinants

1 reference

12 December 2020

Selective in vivo inhibition of T cell activation by class II MHC-binding peptides administered in soluble form

1 reference

12 December 2020

Monoclonal anti-CD4 in arthritis

1 reference

12 December 2020

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

1 reference

12 December 2020

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

1 reference

12 December 2020

The presentation of antigen by MHC class II molecules

1 reference

12 December 2020

In vivo competition between self peptides and foreign antigens in T-cell activation

1 reference

12 December 2020

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00195294

1 reference

9 August 2017

1 reference